CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 64 enrolled
Drug / intervention
Nigella Sativa Oil capsule +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06890546
NCT06890546N/ACompleted

Effect of Nigella Sativa Oil Supplementation and Dietary Intervention on Lipid Profile in Overweight Adults with Hyperlipidemia: a Randomized Controlled Clinical Trial

Istanbul Bilgi University·interventional·Posted Mar 24, 2025·Updated Mar 24, 2025

In Brief

A clinical study evaluating Nigella Sativa Oil capsule and Diet for Hyperlipidaemia and Hyperlipidemia. Completed, enrolled 64 participants across 1 site.

Detailed Summary

Hyperlipidemia is defined as an elevation of plasma cholesterol, lipid, or lipoprotein levels above normal due to abnormal fat metabolism or function, and individuals with hyperlipidemia are approximately twice as likely to develop cardiovascular disease. The first approach to treating hyperlipidemia is lifestyle changes, including dietary therapy and physical activity. In addition to traditional methods, treatments also include pharmacological interventions, and research on natural products and complementary therapies is increasing to increase the effectiveness of these treatment approaches. In this context, Nigella Sativa (NS) oil has emerged as a promising natural option in the treatment of hyperlipidemia and obesity in recent years. The aim of this study was to examine the effects of NS oil supplementation given together with dietary intervention in individuals diagnosed with mild obesity. The main questions it aims to answer are: * Does Nigella Sativa supplementation improve blood lipid profiles in overweight or obese individuals? * Does Nigella Sativa supplementation improve body composition in overweight or obese individuals? Participants were individuals who were diagnosed with hyperlipidemia according to American Heart Association criteria as a result of medical evaluation by a cardiologist and who were deemed appropriate to use black seed oil supplements. Those who volunteered to participate in the study were included in the study. The researchers are examining whether there is any effect on biochemical and anthropometric parameters by giving Nigella Sativa supplementation to a group in addition to a low-calorie diet for eight weeks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedMar 24, 2025
Enrollment StartJun 1, 2023
Primary CompletionFeb 28, 2024
Study CompletionFeb 28, 2025
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 1.3 years ago

Interventions

Nigella Sativa Oil capsuledietary

8 weeks 2 x 900 mg Nigella Sativa oil capsule daily

Dietbehavioral

Low calorie diet intervention